Cannabinoids for Arthritis and Rheumatic Pain: Insufficient Evidence

What Researchers Found About Arthritis and Cannabis

Updated January 25, 2026Schmerz, 2016

The Study at a Glance

Inconclusive

Published

Schmerz, 2016

Researchers

Multiple institutions (International)

Study Type

Systematic Review

Participants

159 patients · 2-5 weeks across studies

Key Finding

Currently, there is insufficient evidence for recommendation for any cannabinoid preparations for symptom management in patients with chronic pain associated with rheumatic diseases.

Key Finding: Currently, there is insufficient evidence for recommendation for any cannabinoid preparations for symptom management in patients with chronic pain associated with rheumatic diseases.

What Researchers Studied About Arthritis and Cannabis

This systematic review searched for randomized controlled trials of cannabinoids for chronic pain in rheumatic diseases.

Conditions studied: fibromyalgia syndrome (FMS), osteoarthritis (OA), chronic spinal pain, and rheumatoid arthritis (RA).

Databases searched: Cochrane CENTRAL, PubMed, cannabis-med.org, and clinicaltrials.gov through April 2015.

How This Systematic Review Was Conducted

Inclusion criteria: RCTs with at least 2 weeks duration and at least 10 patients per treatment arm.

Outcomes assessed: reduction of pain, sleep problems, fatigue, and quality of life limitations for efficacy; dropout rates for tolerability; serious adverse events for safety.

Methodology quality was evaluated by the Cochrane Risk of Bias Tool.

Arthritis Treatment Results

The Main Results:

  • 1Only 4 small RCTs were found for all rheumatic conditions combined
  • 2Two RCTs (2 and 4 weeks) with nabilone in 71 fibromyalgia patients
  • 3One 4-week trial with nabilone in 30 spinal pain patients
  • 4One 5-week study with THC/CBD in 58 rheumatoid arthritis patients
  • 5NO RCTs found for osteoarthritis
  • 6Three studies required pain refractory to conventional treatment
  • 7Risk of bias was HIGH for 3 of 4 studies
  • 8Superiority of cannabinoids over controls (placebo, amitriptyline) was NOT consistent
  • 9Cannabinoids were generally well tolerated despite troublesome side effects
  • 10Cannabinoids were safe during the short study durations

By the Numbers

StatisticWhat It Means
4 RCTsTotal number of qualifying studies found for all rheumatic conditions
159 patientsTotal patients across all 4 studies (71 + 30 + 58)
0 RCTsNumber of studies found for osteoarthritis specifically
3 of 4Studies with high risk of bias
4 RCTs

Total number of qualifying studies found for all rheumatic conditions

159 patients

Total patients across all 4 studies (71 + 30 + 58)

0 RCTs

Number of studies found for osteoarthritis specifically

3 of 4

Studies with high risk of bias

What This Means for Arthritis Patients

If you have arthritis or another rheumatic condition, this review has disappointing news: there is simply not enough evidence to recommend cannabinoids.

Only 4 small, short trials were found across all rheumatic diseases combined. Most had high risk of bias.

For osteoarthritis specifically, NO randomized trials were found at all.

The studies that did exist showed inconsistent results. Cannabinoids were not clearly better than placebo or amitriptyline (a common pain medication).

The good news: cannabinoids appeared safe during these short studies and were generally well tolerated, though some side effects were troublesome.

The bottom line: if you have arthritis, fibromyalgia, or back pain, there is not enough evidence to know whether cannabinoids will help you. More research is needed.

Quick Answers: Arthritis and Cannabis

Direct answers based on the findings of this study:

Research Summary: Answers are based on published peer-reviewed studies and represent research findings, not medical recommendations. Individual results may vary. Always consult a healthcare provider before making treatment decisions.

Is there evidence for cannabis treating arthritis?

Evidence is insufficient. A 2016 systematic review found only 4 small RCTs for all rheumatic diseases combined (159 patients total). Results were inconsistent, risk of bias was high, and NO studies existed for osteoarthritis specifically.

Source: Fitzcharles et al., Schmerz, 2016 (PMID: 26767993)

Should I try cannabis for rheumatoid arthritis?

Current evidence is insufficient to recommend cannabinoids for rheumatoid arthritis. Only one 5-week study with 58 patients exists. Results were not consistent with controls. Discuss with your rheumatologist before trying.

Source: Fitzcharles et al., Schmerz, 2016 (PMID: 26767993)

Why is arthritis not a qualifying condition for medical marijuana?

Because evidence is lacking. A systematic review found only 4 small RCTs for all rheumatic conditions, with inconsistent results and high bias risk. For osteoarthritis specifically, NO randomized trials exist.

Source: Fitzcharles et al., Schmerz, 2016 (PMID: 26767993)

This is educational content, not medical advice

The research summarized here is for informational purposes only. Individual results may vary, and what works in studies may not work the same way for everyone. Always consult with a qualified healthcare provider before making changes to your treatment plan or starting medical cannabis therapy.

Important Limitations

This study has some caveats to keep in mind when interpreting the results:

  • Only 4 small RCTs found across all conditions
  • No RCTs for osteoarthritis
  • High risk of bias in 3 of 4 studies
  • Short study durations (2-5 weeks)
  • Results not consistent across studies
  • Literature search ended April 2015

The Bottom Line on Cannabis for Arthritis

This systematic review found only 4 small, mostly low-quality RCTs for cannabinoids in rheumatic diseases. Results were inconsistent. NO studies existed for osteoarthritis. The conclusion is clear: there is currently insufficient evidence to recommend cannabinoids for arthritis, fibromyalgia, back pain, or rheumatoid arthritis. More research is needed.

Do You Qualify for Medical Marijuana?

If you're living with Arthritis, you may qualify for a medical marijuana card. Our licensed physicians can evaluate you from home via telehealth.

Related Research & Resources

Source

Fitzcharles MA, Baerwald C, Ablin J, et al. "Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials" Schmerz. 2016. DOI: 10.1007/s00482-015-0084-3

Study information sourced from PubMed®, U.S. National Library of Medicine.

Medically Reviewed By

MMJ.com Medical Advisory Board

Last Updated: January 25, 2026

Important Information

Study Age: This study was published 10 years ago. Newer research may have updated or refined these findings.

Not Medical Advice: This research summary is for educational purposes only. It should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult a qualified healthcare provider before starting or changing any treatment.

Individual Variation: Research findings represent group averages. Your individual response to cannabis may differ based on genetics, other medications, underlying conditions, and many other factors.

Last reviewed: January 25, 2026

Important Notices

Research Summary Disclaimer

This content represents our interpretation of published scientific research for educational purposes. It should not be used to make treatment decisions without consulting a qualified healthcare provider. Individual results may vary from study findings.

FDA Notice

These statements have not been evaluated by the FDA. Cannabis is not intended to diagnose, treat, cure, or prevent any disease. The FDA has not approved cannabis for any medical condition except specific prescription medications.

Copyright & Fair Use

Research summaries are provided under fair use (17 U.S.C. § 107) for educational purposes. We provide brief summaries with attribution, not full reproductions. All studies remain the intellectual property of their respective authors and publishers.

Data Sources

Study information sourced from PubMed®, U.S. National Library of Medicine. Inclusion does not imply endorsement by NLM, NIH, or the federal government.

For complete information, see our Terms of Use and Research Content Policy.

FAQs: Cannabis for Arthritis

Does cannabis help arthritis?

There is insufficient evidence to say. A 2016 systematic review found only 4 small RCTs for all rheumatic conditions combined, with inconsistent results and high risk of bias in 3 of 4 studies.

Can I use CBD for osteoarthritis?

There is no evidence from randomized trials. This 2016 review found NO RCTs specifically for osteoarthritis. Without controlled studies, we cannot say whether cannabinoids help this condition.

Are cannabinoids safe for arthritis patients?

Cannabinoids were generally well tolerated and safe during the short study durations (2-5 weeks). However, some side effects were troublesome, and long-term safety is unknown.